Sakai, M.; Nakazawa, N.; Kuriyama, K.; Okada, T.; Shiraishi, T.; Kumakura, Y.; Kimura, A.; Sano, A.; Yokobori, T.; Shirabe, K.;
et al. Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil. Cancers 2026, 18, 112.
https://doi.org/10.3390/cancers18010112
AMA Style
Sakai M, Nakazawa N, Kuriyama K, Okada T, Shiraishi T, Kumakura Y, Kimura A, Sano A, Yokobori T, Shirabe K,
et al. Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil. Cancers. 2026; 18(1):112.
https://doi.org/10.3390/cancers18010112
Chicago/Turabian Style
Sakai, Makoto, Nobuhiro Nakazawa, Kengo Kuriyama, Takuhisa Okada, Takuya Shiraishi, Yuji Kumakura, Akiharu Kimura, Akihiko Sano, Takehiko Yokobori, Ken Shirabe,
and et al. 2026. "Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil" Cancers 18, no. 1: 112.
https://doi.org/10.3390/cancers18010112
APA Style
Sakai, M., Nakazawa, N., Kuriyama, K., Okada, T., Shiraishi, T., Kumakura, Y., Kimura, A., Sano, A., Yokobori, T., Shirabe, K., & Saeki, H.
(2026). Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil. Cancers, 18(1), 112.
https://doi.org/10.3390/cancers18010112
